S
Saija Koskimies
Researcher at Finnish Red Cross
Publications - 111
Citations - 3318
Saija Koskimies is an academic researcher from Finnish Red Cross. The author has contributed to research in topics: Human leukocyte antigen & Antibody. The author has an hindex of 32, co-authored 111 publications receiving 3280 citations. Previous affiliations of Saija Koskimies include University of Helsinki.
Papers
More filters
Journal ArticleDOI
The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort.
Christer Hublin,Jaakko Kaprio,Markku Partinen,Markku Partinen,Markku Koskenvuo,Kauko Heikkilä,Saija Koskimies,Christian Guilleminault +7 more
TL;DR: The tools developed to perform this study, the largest population study of its kind yet performed, can now be used for other population investigations, including that reported in 1945 in the black U.S. population.
Journal ArticleDOI
Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus.
Leif Groop,Maija Kankuri,Camilla Schalin-Jäntti,Agneta Ekstrand,Pirjo Nikula-Ijäs,Elisabeth Widen,Esa Kuismanen,Johan G. Eriksson,A. Franssila-Kallunki,Carola Saloranta,Saija Koskimies +10 more
TL;DR: The Xbal polymorphism of the glycogen synthase gene identifies a subgroup of patients with NIDDM characterized by a strong family history of NID DM, a high prevalence of hypertension, and marked insulin resistance.
Journal ArticleDOI
Serological markers and HLA genes among healthy first-degree relatives of patients with coeliac disease.
Markku Mäki,K. Holm,O. Hällström,Pekka Collin,Markku Viander,Emma M. Savilahti,V. Lipsanen,Saija Koskimies +7 more
TL;DR: It is shown that healthy reticulin-antibody-positive first-degree relatives of coeliac disease patients, irrespective of the state of the jejunal mucosa, are genetically similar to known coeliasis disease patients.
Journal ArticleDOI
secondary Failure to Treatment with Oral Antidiabetic Agents in Non-insulin-dependent Diabetes
TL;DR: Impaired beta cell function is a characteristic feature of many, but not all, NIDD patients who fail on treatment with oral antidiabetic drugs, and the presence of islet cell and thyrogastric antibodies can unmask a distinct group of NIDs patients with a high risk of secondary drug failure and subsequent insulin dependency.
Journal ArticleDOI
Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4.
Carol Forsblom,Timo Sane,Per-Henrik Groop,K. J. Tötterman,Milla Kallio,Carola Saloranta,Leena Laasonen,Paula Summanen,Mauri Lepäntalo,Leila Laatikainen,E. Matikainen,Anna-Maija Teppo,Saija Koskimies,Leif Groop +13 more
TL;DR: In addition to coexisting macroangiopathy, increased albumin excretion rate, poor glycaemic control and neuropathy are risk factors for cardiovascular mortality in patients with Type II diabetes.